CHE

Chemed Corp

480.87

Jul 01 • 04:00PM ET +15.13 (3.25%)

Healthcare Medical Care Facilities USA Mid NYSE

Jul 01, 3:03 PMChemed announces Q2 2026 earnings date, driving 3.61% stock gain

Peers: ENSG UHS DVA AMN CRL DGX LH EVH MMS CHCT

| Held by: IJH VTI VB VBK SDVY VXF XMHQ MDY VIG REGL

Scroll to Statements

Index	-
Market Cap	6.38B
Enterprise Value	6.61B
Income	259.78M
Sales	2.54B
Book/sh	64.15
Cash/sh	1.27
Dividend Est.	4.98 (1.04%)
Dividend TTM	2.40 (0.50%)
Dividend Ex-Date	May 28, 2026
Dividend Gr. 3/5Y	14.13% 10.76%
Payout	11.99%
Employees	15811
IPO	Jun 29, 1982

P/E	26.21
Forward P/E	17.89
PEG	1.75
P/S	2.51
P/B	7.50
P/C	378.60
P/FCF	16.93
EV/EBITDA	16.78
EV/Sales	2.60
Quick Ratio	0.83
Current Ratio	0.85
Debt/Eq	0.29
LT Debt/Eq	0.23
Option/Short	Yes / Yes

EPS (ttm)	18.35
EPS next Y	26.88
EPS next Q	5.60
EPS this Y	12.96%
EPS next Y	10.43%
EPS next 5Y	10.21%
EPS past 3/5Y	3.52% -1.20%
Sales past 3/5Y	5.82% 4.00%
EPS Y/Y TTM	-11.26%
Sales Y/Y TTM	2.07%
EPS Q/Q	-0.35%
Sales Q/Q	1.63%
Earnings	Apr 23 AMC
EPS/Sales Surpr.	6.55% 1.18%

Insider Own	1.85%
Insider Trans	-2.93%
Inst Own	102.64%
Inst Trans	-3.92%
ROA	15.93%
ROE	25.60%
ROIC	24.89%
Gross Margin	29.68%
Oper. Margin	12.93%
Profit Margin	10.23%
SMA20	8.78%
SMA50	11.58%
SMA200	11.87%
Trades

Shs Outstand	13.22M
Shs Float	13.03M
Short Float	4.62%
Short Ratio	2.55
Short Interest	0.60M
52W High	487.98 -1.46%
52W Low	365.20 31.67%
Volatility	2.27% 2.81%
ATR (14)	12.45
RSI (14)	74.72
Beta	0.52
Rel Volume	0.89
Avg Volume	236.16K
Volume	210,535

Perf Week	7.51%
Perf Month	13.72%
Perf Quarter	27.30%
Perf Half Y	10.69%
Perf YTD	12.39%
Perf Year	-0.63%
Perf 3Y	-11.22%
Perf 5Y	-0.33%
Perf 10Y	250.95%
Recom	2.60
Target Price	446.50
Prev Close	465.74
Price	480.87
Change	3.25%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$422
Jan-22-26	Downgrade	Jefferies	Buy → Hold	$475
Sep-02-25	Upgrade	Jefferies	Hold → Buy	$550
Jul-25-25	Initiated	Jefferies	Hold	$500
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$448 → $535
Nov-01-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$490
Sep-06-19	Reiterated	BofA/Merrill	Buy	$470 → $500
Oct-12-18	Initiated	BofA/Merrill	Buy	$390
Aug-28-17	Initiated	KeyBanc Capital Mkts	Sector Weight
Nov-01-16	Reiterated	RBC Capital Mkts	Sector Perform	$162 → $148
Jul-27-16	Reiterated	RBC Capital Mkts	Sector Perform	$136 → $162
May-02-16	Reiterated	RBC Capital Mkts	Sector Perform	$135 → $136
Oct-26-15	Reiterated	RBC Capital Mkts	Sector Perform	$129 → $154
Oct-26-15	Reiterated	Oppenheimer	Outperform	$150 → $152
Sep-22-15	Reiterated	Oppenheimer	Outperform	$147 → $150
Jul-27-15	Reiterated	RBC Capital Mkts	Sector Perform	$110 → $129
Feb-19-15	Reiterated	Oppenheimer	Outperform	$122 → $123
Sep-23-14	Reiterated	Oppenheimer	Outperform	$110 → $115
Jun-10-14	Reiterated	RBC Capital Mkts	Sector Perform	$70 → $74
May-01-14	Reiterated	Oppenheimer	Outperform	$90 → $92

Show Previous Ratings

Jul-01-26 09:00AM	Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29 (GlobeNewswire)
Jun-08-26 03:15PM	Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas (GlobeNewswire)
May-18-26 02:24PM	Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend (GlobeNewswire)
May-13-26 09:00AM	Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference (GlobeNewswire)
May-05-26 09:18AM	Sadness This Mother's Day? VITAS Healthcare Launches Free, Nationwide Mother's Day Grief Helpline (PR Newswire)
09:00AM	Loading…
09:00AM	Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026 (GlobeNewswire)
May-04-26 03:48AM	When Two Temporary Disruptions Get Priced as Permanent at Chemed (GuruFocus.com)
Apr-25-26 03:04AM	Chemed Corp (CHE) Q1 2026 Earnings Call Highlights: Strong VITAS Performance Amid Roto-Rooter ... (GuruFocus.com)
Apr-24-26 08:30AM	Chemed Corporation Q1 2026 Earnings Call Summary (Moby) +9.96%
Apr-23-26 04:47PM	Chemed: Q1 Earnings Snapshot (Associated Press)
04:15PM	Chemed Reports First-Quarter 2026 Results (GlobeNewswire)
Apr-20-26 04:23PM	This Newsletter Has a Multidecade Market-Beating Record. How It Finds Winning Stocks-and Dodges Losers. (Barrons.com)
Apr-13-26 08:15AM	Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement (GlobeNewswire)
Apr-01-26 12:00PM	Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24 (GlobeNewswire)
10:17AM	Roto-Rooter Completes Acquisitions for Two Significant Territories (GlobeNewswire)
12:35PM	Loading…
Mar-16-26 12:35PM	Now Open: VITAS Healthcare Inpatient Hospice Care at Oak Manor (PR Newswire)
Mar-12-26 12:00PM	Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference (GlobeNewswire)
Feb-27-26 08:08PM	Chemed Q4 Earnings Call Highlights (MarketBeat)
12:38PM	CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash (Zacks)
Feb-26-26 04:34PM	Stocks Finish Mostly Lower as Nvidia Weighs on Chipmakers (Barchart) -15.00%
04:03PM	Chemed Corp (CHE) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing Growth ... (GuruFocus.com)
03:01PM	Why Chemed (CHE) Shares Are Plunging Today (StockStory)
12:28PM	Nvidia Slumps Over 4%, Wall Street's Fear Gauge Rallies: What's Moving Markets Thursday? (Benzinga)
11:21AM	Stocks Pressured as Chipmakers Tumble (Barchart)
10:17AM	Stocks Mostly Lower as Nvidia Earnings Fail to Impress (Barchart)
08:30AM	Chemed Corporation Q4 2025 Earnings Call Summary (Moby)
Feb-25-26 05:44PM	Chemed: Q4 Earnings Snapshot (Associated Press Finance)
05:16PM	Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7% (StockStory)
04:15PM	Chemed Reports Fourth-Quarter 2025 Results (GlobeNewswire)
Feb-23-26 10:21PM	Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
11:05PM	Loading…
Feb-16-26 11:05PM	3 Reasons to Sell CHE and 1 Stock to Buy Instead (StockStory)
Feb-13-26 01:20PM	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents (GlobeNewswire)
Feb-03-26 09:01PM	Chemed Corporation (CHE): A Bull Case Theory (Insider Monkey)
Jan-25-26 11:38PM	3 Low-Volatility Stocks We Find Risky (StockStory)
Jan-23-26 09:41AM	Alphabet upgraded, Micron initiated: Wall Streets top analyst calls (TipRanks)
Jan-22-26 12:56PM	Why Chemed (CHE) Shares Are Sliding Today (StockStory)
09:37AM	Alphabet upgraded, Micron initiated: Wall Street's top analyst calls (The Fly)
08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More (24/7 Wall St.)
Jan-02-26 12:00PM	Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26 (GlobeNewswire)
Dec-18-25 07:45AM	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
Dec-09-25 12:00PM	Chemed (CHE) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-04-25 12:00PM	Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference (GlobeNewswire)
Nov-27-25 11:30AM	Chemed (CHE) Down 5.2% Since Last Earnings Report: Can It Rebound? (Zacks)
Nov-25-25 10:50AM	New VITAS Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home (PR Newswire)
Nov-23-25 10:32PM	Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE) (StockStory)
Nov-20-25 10:35PM	Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE) (StockStory)
Nov-11-25 09:55AM	Wall Street Analysts Predict a 32.69% Upside in Chemed (CHE): Here's What You Should Know (Zacks)
Nov-07-25 11:28AM	Chemed Corporation Declares Quarterly Dividend of 60 Cents (GlobeNewswire)
Nov-04-25 12:00PM	Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference (GlobeNewswire)
12:36AM	5 Revealing Analyst Questions From Chemed's Q3 Earnings Call (StockStory)
Oct-30-25 03:48PM	Chemed Corp (CHE) Q3 2025 Earnings Call Highlights: Navigating Revenue Growth Amid Margin Pressures (GuruFocus.com)
Oct-29-25 02:45PM	CHE Q3 CY2025 Deep Dive: Margin Pressure Persists Despite Operational Progress in Core Segments (StockStory) +6.06%
01:11PM	Why Are Chemed (CHE) Shares Soaring Today (StockStory)
09:08AM	CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash (Zacks)
Oct-28-25 05:35PM	Chemed (CHE) Lags Q3 Earnings and Revenue Estimates (Zacks)
04:37PM	Chemed's (NYSE:CHE) Q3 Earnings Results: Revenue In Line With Expectations (StockStory)
04:29PM	Chemed: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports Third-Quarter 2025 Results (GlobeNewswire)
Oct-26-25 11:12PM	Chemed (CHE) Q3 Earnings: What To Expect (StockStory)
Oct-14-25 11:40AM	OPCH or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Oct-08-25 12:04AM	3 Reasons CHE is Risky and 1 Stock to Buy Instead (StockStory)
Oct-07-25 09:37AM	Here's How Chemed Corp. (CHE) Building Long-Term Shareholder Value (Insider Monkey)
Oct-01-25 12:00PM	Chemed To Report Third-Quarter 2025 Earnings October 28, Related Conference Call To Be Held On October 29 (Business Wire)
Sep-25-25 11:48AM	VITAS Healthcare, Leading Hospice Provider, Named a 2025 Top Workplace in Healthcare by Top Workplaces USA (PR Newswire)
Sep-23-25 12:00PM	Chemed Corporation to Present at the Jefferies 2025 Healthcare Services Conference (Business Wire)
Sep-22-25 05:06PM	3 Recession-Ready Stocks That Thrive When the Economy Sputters (MarketBeat)
Sep-16-25 11:43AM	Chemed Corporation (CHE): A Bull Case Theory (Insider Monkey)
Sep-02-25 03:35PM	Why Chemed (CHE) Stock Is Up Today (StockStory)
Aug-28-25 11:30AM	Why Is Chemed (CHE) Up 9.3% Since Last Earnings Report? (Zacks)
Aug-13-25 12:15AM	CHE Q2 Deep Dive: Margin Pressure, Medicare Cap Challenges, and Strategic Repositioning (StockStory)
Aug-12-25 11:42PM	5 Insightful Analyst Questions From Chemed's Q2 Earnings Call (StockStory)
Aug-10-25 11:31PM	Q2 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Aug-01-25 12:50PM	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents (Business Wire)
Jul-31-25 03:20AM	Chemed Corp (CHE) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategic Growth (GuruFocus.com)
Jul-30-25 04:22PM	VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer (GlobeNewswire) -10.36%
02:49PM	Why Chemed Stock Is Plummeting Today (Motley Fool)
01:41PM	Why Chemed (CHE) Stock Is Trading Lower Today (StockStory)
Jul-29-25 06:13PM	Chemed's (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops (StockStory)
06:00PM	Chemed (CHE) Q2 Earnings Miss Estimates (Zacks)
04:56PM	Chemed: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure (Business Wire)
Jul-28-25 11:40AM	ASTH vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Jul-27-25 11:02PM	Chemed (CHE) Q2 Earnings: What To Expect (StockStory)
10:11AM	Chemed updates 2025 forecast as Q1 revenue shows continued growth (Insider Monkey)
Jul-24-25 10:27AM	Chemed Corporation (CHE): A Bull Case Theory (Insider Monkey)
Jul-23-25 08:07AM	Chemed (CHE) Fell due to Concerns Over Potential Medicare Cap Limits (Insider Monkey)
Jul-22-25 10:00AM	Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-17-25 10:38AM	RBC Capital Lowered Firm's PT on Chemed Corporation (CHE), Kept a Buy Rating (Insider Monkey)
Jul-10-25 11:40AM	ASTH or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Jun-30-25 01:47PM	Why Chemed (CHE) Shares Are Plunging Today (StockStory) -12.95%
Jun-27-25 04:15PM	Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 (Business Wire)
07:59AM	Reasons to Add Align Technology Stock to Your Portfolio Now (Zacks)
Jun-20-25 09:48AM	5 Must-Read Analyst Questions From Chemed's Q1 Earnings Call (StockStory)
Jun-08-25 11:31PM	Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers (StockStory)
Jun-06-25 12:02AM	3 Reasons CHE is Risky and 1 Stock to Buy Instead (StockStory)
May-23-25 11:40AM	AMED or CHE: Which Is the Better Value Stock Right Now? (Zacks)
11:30AM	Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue? (Zacks)
May-19-25 02:53PM	Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend (Business Wire)
May-14-25 12:00PM	Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference (Business Wire)
May-06-25 12:00PM	Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025 (Business Wire)

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

CEOMr. Kevin J. McNamara

MBAMr. Michael D. Witzeman CPA

VPMr. Brian C. Judkins J.D.

Executive Vice PresidentMr. Spencer S. Lee

VP & DirectorMr. Thomas C. Hutton J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LINDELL ANDREA R	Director	Jun 09 '26	Sale	447.33	1,347	602,554	4,578	Jun 10 01:05 PM
WALSH GEORGE J III	Director	May 29 '26	Sale	437.83	500	218,915	3,209	May 29 03:42 PM
Patrick P. Grace	Director	May 08 '26	Proposed Sale	425.81	70	29,807		May 08 04:01 PM
GRACE PATRICK P	Director	May 08 '26	Sale	425.78	60	25,547	3,337	May 08 03:32 PM
MCNAMARA KEVIN J	president and CEO	May 01 '26	Sale	421.13	2,000	842,260	90,219	May 04 02:31 PM
KEVIN MCNAMARA	OFFICER	May 01 '26	Proposed Sale	419.85	1,000	419,850		May 01 03:24 PM
MCNAMARA KEVIN J	Officer	May 01 '26	Proposed Sale	420.00	1,000	420,000		May 01 09:23 AM
MCNAMARA KEVIN J	president and CEO	Mar 27 '26	Sale	369.37	1,500	554,055	92,219	Mar 30 12:42 PM
Kevin McNamara	Officer	Mar 27 '26	Proposed Sale	372.57	1,500	558,855		Mar 27 04:02 PM
MCNAMARA KEVIN J	president and CEO	Mar 12 '26	Sale	403.18	2,000	806,360	93,719	Mar 13 12:11 PM
Kevin McNamara	Officer	Mar 12 '26	Proposed Sale	403.82	1,000	403,820		Mar 12 03:29 PM
MCNAMARA KEVIN J	Officer	Mar 12 '26	Proposed Sale	404.79	1,000	404,790		Mar 12 01:28 PM
LEE SPENCER S	executive vice president	Feb 13 '26	Option Exercise	469.56	499	234,310	15,066	Feb 17 04:50 PM
HUTTON THOMAS C	vice president	Feb 13 '26	Option Exercise	469.56	199	93,442	32,553	Feb 17 04:36 PM
Wherley Joel L	CEO - Vitas Healthcare	Feb 13 '26	Option Exercise	469.56	273	128,190	932	Feb 17 03:58 PM
Witzeman Michael D	VP & Chief Financial Officer	Feb 13 '26	Option Exercise	469.56	413	193,928	6,073	Feb 17 03:37 PM
MCNAMARA KEVIN J	president and CEO	Feb 13 '26	Option Exercise	469.56	2,714	1,274,386	96,911	Feb 17 03:14 PM
Judkins Brian C	VP and Chief Legal Officer	Feb 13 '26	Option Exercise	469.56	351	164,816	2,538	Feb 17 02:33 PM
Nicholas Westfall	former officer	Dec 11 '25	Proposed Sale	430.62	942	405,645		Dec 11 12:22 PM
MCNAMARA KEVIN J	president and CEO	Nov 24 '25	Sale	437.55	2,000	875,100	94,197	Nov 25 02:47 PM
MCNAMARA KEVIN J	Officer	Nov 24 '25	Proposed Sale	438.00	2,000	876,000		Nov 24 01:24 PM
MCNAMARA KEVIN J	president and CEO	Sep 26 '25	Sale	461.28	3,000	1,383,840	96,197	Sep 29 11:59 AM
Kevin McNamara	Officer	Sep 26 '25	Proposed Sale	428.55	2,000	857,107		Sep 29 11:57 AM
MCNAMARA KEVIN J	Officer	Sep 26 '25	Proposed Sale	460.00	1,000	460,000		Sep 26 03:35 PM
GRACE PATRICK P	Director	Sep 09 '25	Sale	463.39	150	69,508	3,397	Sep 10 11:51 AM
Patrick P. Grace	Director	Sep 09 '25	Proposed Sale	463.78	150	69,567		Sep 09 05:10 PM
RICE THOMAS P	Director	Jul 31 '25	Proposed Sale	418.01	556	232,411		Aug 22 11:18 AM
MCNAMARA KEVIN J	president and CEO	Aug 05 '25	Sale	428.55	2,000	857,100	99,197	Aug 05 04:42 PM
MCNAMARA KEVIN J	Officer	Aug 05 '25	Proposed Sale	428.73	2,000	857,460		Aug 05 04:10 PM
WALSH GEORGE J III	Director	Aug 04 '25	Buy	417.10	200	83,420	3,523	Aug 05 03:24 PM
Westfall Nicholas Michael	Executive Vice President	Aug 04 '25	Sale	421.91	10,012	4,224,163	0	Aug 05 10:30 AM
Nicholas M Westfall	Officer	Aug 04 '25	Proposed Sale	417.85	10,012	4,183,514		Aug 04 04:50 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

CHE

Chemed Corp

Upgrade your Finviz experience